These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

840 related items for PubMed ID: 26787792

  • 1. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,
    Kaufhold N, Schaller SJ, Stäuble CG, Baumüller E, Ulm K, Blobner M, Fink H.
    Br J Anaesth; 2016 Feb; 116(2):233-40. PubMed ID: 26787792
    [Abstract] [Full Text] [Related]

  • 2. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, Nakatsuka I, Takeda J.
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
    Hristovska AM, Duch P, Allingstrup M, Afshari A.
    Cochrane Database Syst Rev; 2017 Aug 14; 8(8):CD012763. PubMed ID: 28806470
    [Abstract] [Full Text] [Related]

  • 4. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA, Mastronardi P, Hunter JM, Gomar C, Mirakhur RK, Aguilera L, Giunta FG, Meistelman C, Prins ME.
    Br J Anaesth; 2008 May 14; 100(5):622-30. PubMed ID: 18385265
    [Abstract] [Full Text] [Related]

  • 5. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK, Caldwell JE, Brull SJ, Soto RG.
    Anesthesiology; 2008 Nov 14; 109(5):816-24. PubMed ID: 18946293
    [Abstract] [Full Text] [Related]

  • 6. Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: a large observational study.
    Della Rocca G, Pompei L, Pagan DE Paganis C, Tesoro S, Mendola C, Boninsegni P, Tempia A, Manstretta S, Zamidei L, Gratarola A, Murabito P, Fuggiano L, DI Marco P.
    Acta Anaesthesiol Scand; 2013 Oct 14; 57(9):1138-45. PubMed ID: 23849107
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Management of Muscle Relaxation With Rocuronium and Reversal With Neostigmine or Sugammadex Guided by Quantitative Neuromuscular Monitoring.
    Thilen SR, Sherpa JR, James AM, Cain KC, Treggiari MM, Bhananker SM.
    Anesth Analg; 2024 Sep 01; 139(3):536-544. PubMed ID: 37171989
    [Abstract] [Full Text] [Related]

  • 11. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia.
    Dahaba AA, Bornemann H, Hopfgartner E, Ohran M, Kocher K, Liebmann M, Wilfinger G, Metzler H.
    Br J Anaesth; 2012 Apr 01; 108(4):602-6. PubMed ID: 22315331
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing.
    Eikermann M, Zaremba S, Malhotra A, Jordan AS, Rosow C, Chamberlin NL.
    Br J Anaesth; 2008 Sep 01; 101(3):344-9. PubMed ID: 18559352
    [Abstract] [Full Text] [Related]

  • 15. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA.
    Anesth Analg; 2010 Jan 01; 110(1):64-73. PubMed ID: 19713265
    [Abstract] [Full Text] [Related]

  • 16. Reversal of Partial Neuromuscular Block and the Ventilatory Response to Hypoxia: A Randomized Controlled Trial in Healthy Volunteers.
    Broens SJL, Boon M, Martini CH, Niesters M, van Velzen M, Aarts LPHJ, Dahan A.
    Anesthesiology; 2019 Sep 01; 131(3):467-476. PubMed ID: 31045894
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
    Czarnetzki C, Tassonyi E, Lysakowski C, Elia N, Tramèr MR.
    Anesthesiology; 2014 Jul 01; 121(1):59-67. PubMed ID: 24608361
    [Abstract] [Full Text] [Related]

  • 18. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A, Ho J, Wong J, Yin L, Chung F.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007362. PubMed ID: 19821409
    [Abstract] [Full Text] [Related]

  • 19. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P, Kuizenga K, Saldien V, Claudius C, Servin F, Klein J, Debaene B, Heeringa M.
    Anesth Analg; 2010 Jan 01; 110(1):74-82. PubMed ID: 19933538
    [Abstract] [Full Text] [Related]

  • 20. Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects.
    Wu X, Oerding H, Liu J, Vanacker B, Yao S, Dahl V, Xiong L, Claudius C, Yue Y, Huang Y, Abels E, Rietbergen H, Woo T.
    BMC Anesthesiol; 2014 Jan 01; 14():53. PubMed ID: 25187755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.